Literature DB >> 15820559

Role of claudins in tumorigenesis.

Karen Swisshelm1, Robert Macek, Manfred Kubbies.   

Abstract

The family of more than 20 claudin (CLDN) proteins comprises one of the major structural elements within the apical tight junction apparatus, a dynamic cellular nexus for maintenance of a luminal barrier, paracellular transport, and signal transduction. Loss of normal tight junction functions constitutes a hallmark of human carcinomas. CLDN1 may support tumor suppressive functions in tissues such as the brain, where dramatic loss of expression has been demonstrated in glioblastoma multiforme. The role(s) for CLDNs 3 and 4 in tumorigenesis is less clear. CLDN4 appears to be over-expressed in ovarian and pancreatic carcinomas, and this raises the possibility that a unique, potentially non-toxic cancer cell target may be developed through the design of enterotoxin analogues. Future goals include understanding the biochemical and physiological mechanisms that are perturbed as a consequence of CLDN alterations in the progression of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820559     DOI: 10.1016/j.addr.2005.01.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  69 in total

1.  Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells.

Authors:  Theresa D'Souza; Fred E Indig; Patrice J Morin
Journal:  Exp Cell Res       Date:  2007-07-13       Impact factor: 3.905

2.  Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.

Authors:  Babak Litkouhi; Joseph Kwong; Chun-Min Lo; James G Smedley; Bruce A McClane; Margarita Aponte; Zhijian Gao; Jennifer L Sarno; Jennifer Hinners; William R Welch; Ross S Berkowitz; Samuel C Mok; Elizabeth I O Garner
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

Review 3.  Cell biology and physiology of the uroepithelium.

Authors:  Puneet Khandelwal; Soman N Abraham; Gerard Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

4.  Claudin-1 expression in cervical cancer.

Authors:  Friederike Hoellen; Annika Waldmann; Constanze Banz-Jansen; Uwe Holtrich; Thomas Karn; Martina Oberländer; Jens K Habermann; Mareike Hörmann; Frank Köster; Julika Ribbat-Idel; Marc Thill; Achim Rody; Ahmed El-Balat; Lars Hanker
Journal:  Mol Clin Oncol       Date:  2017-08-25

5.  Identification of MarvelD3 as a tight junction-associated transmembrane protein of the occludin family.

Authors:  Emily Steed; Nelio T L Rodrigues; Maria S Balda; Karl Matter
Journal:  BMC Cell Biol       Date:  2009-12-22       Impact factor: 4.241

6.  CLDN-1 promoted the epithelial to migration and mesenchymal transition (EMT) in human bronchial epithelial cells via Notch pathway.

Authors:  Jing Lv; Baohua Sun; Zhitao Mai; Mingming Jiang; Junfeng Du
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

7.  Expression of Claudin-1 in laryngeal squamous cell carcinomas (LSCCs) and its significance.

Authors:  Abderrahman Ouban
Journal:  Histol Histopathol       Date:  2021-02-25       Impact factor: 2.303

8.  Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.

Authors:  Zsuzsanna Németh; Attila Marcell Szász; Péter Tátrai; Júlia Németh; Hajnalka Gyorffy; Aron Somorácz; Attila Szíjártó; Péter Kupcsulik; András Kiss; Zsuzsa Schaff
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

9.  Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas.

Authors:  Erika Rendón-Huerta; Fortoul Teresa; Gorráez María Teresa; Garcia-Samper Xochitl; Alvarez-Fernández Georgina; Zavala-Zendejas Veronica; Luis Felipe Montaño
Journal:  J Gastrointest Cancer       Date:  2009-12-04

10.  Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers.

Authors:  Yvonne Myal; Etienne Leygue; Anne A Blanchard
Journal:  J Biomed Biotechnol       Date:  2010-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.